EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway

Shuai Xiao, Junjie Chen, Yongbao Wei, Wei Song

European Journal of Medical Research · 2024

DOI: 10.1186/s40001-024-01889-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Medical Research, 2024. Verfasst von Shuai Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410011, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Hunan Provincial People's Hospital Doctoral Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The basic helix-loop-helix family member e41 (BHLHE41) is frequently dysregulated in tumors and plays a crucial role in malignant progression of various cancers. Nevertheless, its specific function and underlying mechanism in bladder cancer (BCa) remain largely unexplored.

Methods

The expression levels of BHLHE41 in BCa tissues and cells were examined by qRT-PCR and western blot assays. BCa cells stably knocking down or overexpressing BHLHE41 were constructed through lentivirus infection. The changes of cell proliferation, cell cycle distribution, migration, and invasion were detected by CCK-8, flow cytometry, wound healing, transwell invasion assays, respectively. The expression levels of related proteins were detected by western blot assay. The interaction between BHLHE41 and PYCR1 was explored by co-immunoprecipitation analysis.

Results

In this study, we found that BHLHE41 was lowly expressed in bladder cancer tissues and cell lines, and lower expression of BHLHE41 was associated with poor overall survival in bladder cancer patients. Functionally, by manipulating the expression of BHLHE41, we demonstrated that overexpression of BHLHE41 significantly retarded cell proliferation, migration, invasion, and induced cell cycle arrest in bladder cancer through various in vitro and in vivo experiments, while silence of BHLHE41 caused the opposite effect. Mechanistically, we showed that BHLHE41 directly interacted with PYCR1, decreased its stability and resulted in the ubiquitination and degradation of PYCR1, thus inactivating PI3K/AKT signaling pathway. Rescue experiments showed that the effects induced by BHLHE41 overexpression could be attenuated by further upregulating PYCR1.

Conclusion

BHLHE41 might be a useful prognostic biomarker and a tumor suppressor in bladder cancer. The BHLHE41/PYCR1/PI3K/AKT axis might be a potential therapeutic target for bladder cancer intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionPyrroline Carboxylate ReductasesCell Proliferationdelta-1-Pyrroline-5-Carboxylate ReductaseHumansBasic Helix-Loop-Helix ProteinsCell MovementDisease ProgressionGene Expression Regulation, NeoplasticCell Line, TumorMiceAnimalsMale

Stichwörter der Autor:innen

BHLHE41Bladder cancerPI3K/AKT signaling pathwayPYCR1Ubiquitination

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPyrroline Carboxylate Reductasesdelta-1-Pyrroline-5-Carboxylate ReductaseBasic Helix-Loop-Helix Proteins

Autor:innen und Institutionen

  • Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410011, China.
  • Department of Urology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China. weiyb@fjmu.edu.cn.
  • Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410011, China. drsongw@126.com.

Förderung

  • Natural Science Foundation of Hunan Province
  • Hunan Provincial People's Hospital Doctoral Fund Project

Zitieren

APA

Xiao, S., Chen, J., Wei, Y., & Song, W. (2024). BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway. European Journal of Medical Research. https://doi.org/10.1186/s40001-024-01889-2

Vancouver

Xiao S, Chen J, Wei Y, Song W. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway. European Journal of Medical Research. 2024. doi:10.1186/s40001-024-01889-2

BibTeX
@article{Xiao2024,
  author = {Xiao, Shuai and Chen, Junjie and Wei, Yongbao and Song, Wei},
  title = {BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway},
  journal = {European Journal of Medical Research},
  year = {2024},
  doi = {10.1186/s40001-024-01889-2}
}
Kostenlos starten →